Anthropic CEO Amodei pushes back on Baker's AI regulation criticism
Anthropic CEO Dario Amodei refuted investor Gavin Baker's claims about the company's regulatory stance and private status. Amodei argued that targeted AI regulations can strengthen competition rather than concentrate power, while defending his balanced approach to discussing AI risks and benefits. The debate occurs as Anthropic projects significant revenue growth, expecting $190 billion to $200 billion by 2028 compared to a $47 billion annualized run rate in May.

*this image is generated using AI for illustrative purposes only.
Anthropic CEO Dario Amodei has pushed back against criticism from investor Gavin Baker, arguing that carefully designed artificial intelligence regulations can limit the power of frontier labs without undermining competition or open-weight models. The debate centers on Baker's assertion that Amodei's public messaging suggests Anthropic might become the only private company in the world, a claim an Anthropic employee called "completely false."
Amodei addressed the controversy directly, stating that the choice between concentrating AI power in the hands of a few companies and governments versus distributing it widely is a "false choice." He argued that regulations can impose tougher requirements on frontier AI companies while giving smaller competitors more room to develop, potentially strengthening market competition.
Regulatory Stance and Public Messaging
Baker, managing partner and chief investment officer at Atreides Management, had appeared on the All-In podcast to voice concerns about Amodei's push for stricter AI regulation. Baker argued that concentrating powerful AI systems among a small group of companies and governments could be more dangerous than widely distributing the technology, citing Meta Platforms Inc. (NASDAQ: META) CEO Mark Zuckerberg's similar arguments.
Amodei disagreed with this framing, noting that he supports the Donald Trump administration's reported approach of pre-deployment testing for frontier AI models. He also supported testing advanced open-weight models, despite reports that the White House told major AI companies that open-weight models would be exempt from planned AI safety testing.
Regarding his public communications, Amodei rejected Baker's criticism that his messaging has been disproportionately negative toward AI. He stated that Anthropic has discussed both the risks and potential benefits of advanced AI, including major breakthroughs in medicine and biology. Amodei attributed the negative public perception of AI to a broader "crisis of trust" rather than his specific messaging.
Revenue Growth Context
The regulatory debate unfolds against a backdrop of significant financial growth for Anthropic. The company reportedly expects to generate $190 billion to $200 billion in revenue by 2028, a substantial increase from its roughly $47 billion annualized revenue run rate in May.
| Metric: | Value: | Period: |
|---|---|---|
| Annualized Revenue Run Rate: | $47 billion | May 2026 |
| Q2 2026 Expected Revenue: | At least $10.9 billion | Q2 2026 |
| End-of-Year Run Rate: | About $9 billion | End of 2025 |
| Projected 2028 Revenue: | $190 billion to $200 billion | 2028 |
For the second quarter of 2026, Anthropic expects revenue of at least $10.9 billion, more than double the previous quarter. This rapid growth trajectory underscores the increasing financial stakes in the AI sector as companies navigate evolving regulatory landscapes.
What the Numbers Show
The divergence between Anthropic's rapid revenue growth and the ongoing regulatory debate highlights a critical tension in the AI industry. While the company's financial metrics show explosive expansion—from a $9 billion run rate at the end of 2025 to a projected $190 billion to $200 billion by 2028—the regulatory framework remains unsettled. Amodei's defense of targeted regulation for frontier models suggests that Anthropic views compliance not as a barrier to growth, but as a mechanism that could shape competitive dynamics in its favor by imposing heavier burdens on larger players while allowing smaller competitors space to develop.
How might the proposed pre-deployment testing requirements for frontier models impact Anthropic's projected $190 billion to $200 billion revenue trajectory by 2028?
Could the regulatory distinction between frontier labs and open-weight models create a sustainable competitive moat for Anthropic against rivals like Meta?
What are the potential market reactions if smaller AI competitors leverage lighter regulatory burdens to capture significant market share from established frontier labs?

































